No Data
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAvidity Biosciences (NASDAQ:RNA) shares rose 24.5% to $36.0 during Wednesday's pre-market session. The company's market cap stands at $3.4 billion. Molecular Partners (NASDAQ:MOLN) shares moved
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersVenus Concept (NASDAQ:VERO) stock rose 131.0% to $1.43 during Thursday's after-market session. The market value of their outstanding shares is at $9.0 million. Cyclacel Pharmaceuticals (NASDAQ:
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Roth MKM Maintains Cyclacel Pharmaceuticals(CYCC.US) With Buy Rating, Cuts Target Price to $11
Roth MKM analyst Jonathan Aschoff maintains $Cyclacel Pharmaceuticals(CYCC.US)$ with a buy rating, and adjusts the target price from $240 to $11.According to TipRanks data, the analyst has a success r
Express News | Cyclacel Pharmaceuticals: Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at 2024 Asco Annual Meeting
Cyclacel Pharmaceuticals To Present Clinical Data At 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib's Potential As A Precision Medicine For Cancer
- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study in patients with solid tumors and lymphoma -BERKELEY HEIGHTS, N.J., June 0
No Data